Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 5/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.56 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | KAT2B | Q92831 | 4/20 | 0.55 |
| ▸ | EP300 | Q09472 | 3/20 | 0.55 |
| ▸ | MPI | P34949 | 1/20 | 0.55 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.55 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1899386 | 0.83 | IDO1 (0.71) | IDO1HTTHPGDALDH1A1TDP1 | |
| SCHEMBL28924298 | 0.81 | IDO1 (0.67) | IDO1HPGDALDH1A1HSP90AA1TDP1 | |
| SCHEMBL2136307 | 0.76 | IDO1 (0.60) | IDO1HTTHPGDALDH1A1HSP90AA1 | |
| SCHEMBL87450 | 0.75 | CA1 (0.83) | HTTHPGDALDH1A1HSP90AA1CACNA1B | |
| SCHEMBL9616912 | 0.74 | IDO1 (0.59) | IDO1HPGDALDH1A1KAT2BEP300 | |
| SCHEMBL9263510 | 0.74 | SMN1; SMN2 (0.60) | IDO1HTTHPGDALDH1A1HSP90AA1 | |
| SCHEMBL29504635 | 0.73 | CA1 (0.79) | HTTHPGDALDH1A1HSP90AA1CACNA1B | |
| SCHEMBL30271267 | 0.73 | CA1 (0.79) | HTTHPGDALDH1A1HSP90AA1CACNA1B | |
| SCHEMBL21440358 | 0.73 | CA1 (0.79) | HTTHPGDALDH1A1HSP90AA1CACNA1B | |
| SCHEMBL7746905 | 0.73 | CA1 (0.79) | HTTHPGDALDH1A1HSP90AA1CACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3980400-B1 | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | UNIV EMORY (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20250114389-A1 | NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS | UNIV EMORY (US) | 2025-04-10 | — | — | US | disclosed |
| US-12268723-B2 | Peptidomimetics for the treatment of coronavirus and picorna virus infections | EMORY UNIVERSITY (US) | 2025-04-08 | — | — | US | disclosed |
| US-20240238323-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | EMORY UNIVERSITY | 2024-07-18 | — | — | US | disclosed |
| US-20240216413-A1 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS | EMORY UNIVERSITY (US) | 2024-07-04 | — | — | US | disclosed |
| CN-117881403-A | Thionucleosides as antiviral agents | 爱莫里大学 | 2024-04-12 | — | — | CN | disclosed |
| CN-117858711-A | Nucleoside and nucleotide analogs as antiviral agents | 爱莫里大学 | 2024-04-09 | — | — | CN | disclosed |
| EP-4319764-A2 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS | Emory University (US) | 2024-02-14 | — | — | EP | disclosed |
| EP-4319763-A2 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | Emory University (US) | 2024-02-14 | — | — | EP | disclosed |
| EP-4319762-A2 | NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS | Emory University (US) | 2024-02-14 | — | — | EP | disclosed |
| US-11207370-B2 | Peptidomimetics for the treatment of coronavirus and picornavirus infections | EMORY UNIVERSITY (US) | 2021-12-28 | — | — | US | disclosed |
| US-20210008150-A1 | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | EMORY UNIVERSITY | 2021-01-14 | — | — | US | disclosed |
| WO-2020247665-A1 | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | EMORY UNIVERSITY (US) | 2020-12-10 | — | — | WO | disclosed |
| EP-0331319-B1 | Method for the formation of images | KONISHIROKU PHOTO IND (JP) | 1994-01-26 | — | — | EP | disclosed |
| US-H1090-H | High contrast; hydrazide, isothizolone, bromonitroalcohol | KONICA CORPORATION (JP) | 1992-08-04 | — | — | US | disclosed |
| EP-0356801-A1 | Light-sensitive silver halide photographic material | KONICA CORPORATION (JP) | 1990-03-07 | — | — | EP | disclosed |
| EP-0331319-A1 | Method for the formation of images | KONICA CORPORATION (JP) | 1989-09-06 | — | — | EP | disclosed |
| EP-0090584-B1 | LIGHT-SENSITIVE SILVER HALIDE PHOTOGRAPHIC MATERIAL | KONICA CORPORATION (JP) | 1986-12-03 | — | — | EP | disclosed |
| US-4490462-A | CONTAINING ISOTHIAZOLIN-3-ONE MICROBIOCIDE OR FUNGICIDE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-12-25 | — | — | US | disclosed |
| EP-0090584-A2 | Light-sensitive silver halide photographic material | KONICA CORPORATION (JP) | 1983-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216413-A1 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS | MTAP, NSUN3, METTL3 | IDO1 727/4885HTT 1282/4885HPGD 4098/4885 |
| US-20210008150-A1 | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | ACE2, SARS1, VIP | IDO1 967/4885HTT 1949/4885HPGD 3750/4885 |
| US-12268723-B2 | Peptidomimetics for the treatment of coronavirus and picorna virus infections | ACE2, SARS1, HAVCR2 | IDO1 996/4885HTT 1855/4885HPGD 3654/4885 |
| US-20250114389-A1 | NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS | PNP, MTAP, NOP2 | IDO1 825/4885HTT 2478/4885HPGD 3411/4885 |
| US-20240238323-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | MTAP, PNP, SARS1 | IDO1 1048/4885HTT 2980/4885HPGD 3721/4885 |
| US-11207370-B2 | Peptidomimetics for the treatment of coronavirus and picornavirus infections | ACE2, SARS1, VIP | IDO1 967/4885HTT 1949/4885HPGD 3750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.